Why Endo Health Solutions Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of drugmaker Endo Health Solutions jumped 29% today after announcing a major acquisition.
So what: Endo Health Solutions is buying specialty drugmaker Paladin Labs for $1.5 billion, and the new company will then be moved into an Irish holding company. Paladin Labs shareholders will get 1.6331 shares of the new company, $1.11, and one share of Knight Therapeutics -- a new company as part of the spinoff. Endo Health Solutions shareholders will get one share of the new company.
To top it off, adjusted earnings per share for last quarter hit $1.34, and revenue was $715 million -- both down from a year ago but well ahead of expectations.
Now what: Shares of both Endo Health Solutions and Paladin Labs have jumped today, so investors clearly think the combined company is worth more than the companies separately. For investors who owned the stock yesterday, this may be a day to take some gains off the table. It will take time for the merger to go through, and with Endo Health's revenue deteriorating, I don't see another big catalyst until the companies combine and begin generating strong growth, which will take a while.
A big catalyst hitting the health care industry
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called Everything You Need to Know About Obamacare. But don't hesitate; because it's not often that we release a FREE guide containing this much information and money-making advice. Please click here to access your free copy.
The article Why Endo Health Solutions Shares Jumped originally appeared on Fool.com.
Fool contributor Travis Hoium has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
